{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:08:09Z","timestamp":1791162489439,"version":"4.1.0"},"reference-count":65,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T00:00:00Z","timestamp":1434931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0128648","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T18:07:50Z","timestamp":1434996470000},"page":"e0128648","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":61,"title":["Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet"],"prefix":"10.1371","volume":"10","author":[{"given":"Komal","family":"Sodhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Favero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader G.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Rezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden","family":"Ansinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Lebovics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph I.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,6,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"G Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"CD Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"178","author":"M Lazo","year":"2013","journal-title":"Am J Epidemiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.3748\/wjg.v13.i26.3540","article-title":"Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease","volume":"13","author":"K Qureshi","year":"2007","journal-title":"World J Gastroenterol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"G Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1464-5491.2005.01748.x","article-title":"Recent concepts in non-alcoholic fatty liver disease","volume":"22","author":"LA Adams","year":"2005","journal-title":"Diabet Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejim.2007.02.034","article-title":"Evolving trends in nonalcoholic fatty liver disease","volume":"19","author":"JS Delgado","year":"2008","journal-title":"Eur J Intern Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2174\/138161210791208875","article-title":"Insulin resistance in nonalcoholic fatty liver disease","volume":"16","author":"E Bugianesi","year":"2010","journal-title":"Curr Pharm Des"},{"key":"ref9","first-page":"783976","article-title":"Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation","volume":"2011","author":"TK Fon","year":"2011","journal-title":"J Lipids"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ajg.2009.67","article-title":"NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study","volume":"104","author":"LA Adams","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/jc.2012-3093","article-title":"Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications","volume":"98","author":"G Targher","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1556\/OH.2008.28418","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk","volume":"149","author":"T Abel","year":"2008","journal-title":"Orv Hetil"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"M Gaggini","year":"2013","journal-title":"Nutrients"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2006.08.021","article-title":"Non-alcoholic fatty liver disease and increased risk of cardiovascular disease","volume":"191","author":"G Targher","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.atherosclerosis.2013.07.052","article-title":"A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?","volume":"230","author":"ET Oni","year":"2013","journal-title":"Atherosclerosis"},{"key":"ref16","first-page":"441","article-title":"Molecular mechanisms of steatosis in nonalcoholic fatty liver disease","volume":"26","author":"P Pettinelli","year":"2011","journal-title":"Nutr Hosp"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/hep.25741","article-title":"Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes","volume":"56","author":"MF Abdelmalek","year":"2012","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease","volume":"51","author":"MF Abdelmalek","year":"2010","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3748\/wjg.v19.i8.1166","article-title":"Fructose as a key player in the development of fatty liver disease","volume":"19","author":"M Basaranoglu","year":"2013","journal-title":"World J Gastroenterol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","article-title":"The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome","volume":"7","author":"JS Lim","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jnutbio.2011.09.006","article-title":"The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease","volume":"23","author":"K Nomura","year":"2012","journal-title":"J Nutr Biochem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3748\/wjg.v19.i8.1166","article-title":"Fructose as a key player in the development of fatty liver disease","volume":"19","author":"M Basaranoglu","year":"2013","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1755-1536-6-14","article-title":"Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar?","volume":"6","author":"L Longato","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6552","DOI":"10.3748\/wjg.v18.i45.6552","article-title":"Way back for fructose and liver metabolism: bench side to molecular insights","volume":"18","author":"A Rebollo","year":"2012","journal-title":"World J Gastroenterol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/er.2008-0033","article-title":"Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?","volume":"30","author":"RJ Johnson","year":"2009","journal-title":"Endocr Rev"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11695-007-9087-1","article-title":"IL-6 and IGF-1 are independent prognostic factors of liver steatosis and non-alcoholic steatohepatitis in morbidly obese patients","volume":"17","author":"D Garcia-Galiano","year":"2007","journal-title":"Obes Surg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/hep.510300236","article-title":"MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells","volume":"30","author":"N Theret","year":"1999","journal-title":"Hepatology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1097\/01.ALC.0000078614.44983.97","article-title":"Ethanol induces transforming growth factor-alpha expression in hepatocytes, leading to stimulation of collagen synthesis by hepatic stellate cells","volume":"27","author":"J Kato","year":"2003","journal-title":"Alcohol Clin Exp Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/jcb.24061","article-title":"Heme induced oxidative stress attenuates sirtuin1 and enhances adipogenesis in mesenchymal stem cells and mouse pre-adipocytes","volume":"113","author":"N Puri","year":"2012","journal-title":"J Cell Biochem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"E1179","DOI":"10.1152\/ajpendo.90997.2008","article-title":"Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice","volume":"297","author":"Y Yamazaki","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation","volume":"9","author":"A Purushotham","year":"2009","journal-title":"Cell Metab"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.abb.2010.05.003","article-title":"Regulation of SIRT1 in cellular functions: role of polyphenols","volume":"501","author":"S Chung","year":"2010","journal-title":"Arch Biochem Biophys"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1096\/fj.03-0229fje","article-title":"Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury","volume":"17","author":"PO Berberat","year":"2003","journal-title":"FASEB J"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2337\/db07-1764","article-title":"Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance","volume":"57","author":"M Li","year":"2008","journal-title":"Diabetes"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/HYPERTENSIONAHA.112.193805","article-title":"Heme oxygenase gene targeting to adipocytes attenuates adiposity and vascular dysfunction in mice fed a high-fat diet","volume":"60","author":"J Cao","year":"2012","journal-title":"Hypertension"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/pr.107.07104","article-title":"Pharmacological and clinical aspects of heme oxygenase","volume":"60","author":"NG Abraham","year":"2008","journal-title":"Pharmacol Rev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.1006962107","article-title":"Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway","volume":"107","author":"MD Chau","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1210\/en.2007-0014","article-title":"Peroxisome proliferator-activated receptor alpha protects against obesity-induced hepatic inflammation","volume":"148","author":"R Stienstra","year":"2007","journal-title":"Endocrinology"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Hinds TD Jr, Sodhi K, Meadows C, Fedorova L, Puri N, Kim DH, et al. Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21. Obesity (Silver Spring) 2013.","DOI":"10.1002\/oby.20559"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0167-4838(86)90238-4","article-title":"Effects of iron deficiency and chronic iron overloading on mitochondrial heme biosynthetic enzymes in rat liver","volume":"870","author":"NG Abraham","year":"1986","journal-title":"Biochim Biophys Acta"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00000441-199403000-00003","article-title":"Tin-mediated heme oxygenase gene activation and cytochrome P450 arachidonate hydroxylase inhibition in spontaneously hypertensive rats","volume":"307","author":"JL da Silva","year":"1994","journal-title":"Am J Med Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1111\/j.1523-1755.2005.00745.x","article-title":"Increase in heme oxygenase-1 levels ameliorates renovascular hypertension","volume":"68","author":"FT Botros","year":"2005","journal-title":"Kidney Int"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.prostaglandins.2011.12.004","article-title":"EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels","volume":"98","author":"K Sodhi","year":"2012","journal-title":"Prost Other Lipid Mediat"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"22510","DOI":"10.1073\/pnas.0912533106","article-title":"PGC-1alpha negatively regulates hepatic FGF21 expression by modulating the heme\/Rev-Erb(alpha) axis","volume":"106","author":"JL Estall","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1034\/j.1600-0676.2003.00805.x","article-title":"Reduced hepatic glycogen stores in patients with liver cirrhosis","volume":"23","author":"L Krahenbuhl","year":"2003","journal-title":"Liver Int"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.110.151423","article-title":"Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice","volume":"56","author":"A Burgess","year":"2010","journal-title":"Hypertension"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/HYPERTENSIONAHA.108.124701","article-title":"Heme Oxygenase-1 Induction Remodels Adipose Tissue and Improves Insulin Sensitivity in Obesity-Induced Diabetic Rats","volume":"53","author":"A Nicolai","year":"2009","journal-title":"Hypertension"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/jpet.107.135285","article-title":"Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines, tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells","volume":"325","author":"DH Kim","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3748\/wjg.v18.i14.1680","article-title":"Heme oxygenase-1 prevents liver fibrosis in rats by regulating the expression of PPARgamma and NF-kappaB","volume":"18","author":"H Yang","year":"2012","journal-title":"World J Gastroenterol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/ajcn\/76.5.911","article-title":"Fructose, weight gain, and the insulin resistance syndrome","volume":"76","author":"SS Elliott","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/138161208783597371","article-title":"Heme oxygenase: a target gene for anti-diabetic and obsesity","volume":"14","author":"N Abraham","year":"2008","journal-title":"Curr Pharm Des"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"H1394","DOI":"10.1152\/ajpheart.00584.2011","article-title":"Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy","volume":"302","author":"AN Higdon","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.clinbiochem.2005.01.013","article-title":"Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats","volume":"38","author":"F Armutcu","year":"2005","journal-title":"Clin Biochem"},{"key":"ref54","first-page":"290104","article-title":"Carvacrol Protects against Hepatic Steatosis in Mice Fed a High-Fat Diet by Enhancing SIRT1-","volume":"2013","author":"E Kim","year":"2013","journal-title":"AMPK Signaling. Evid Based Complement Alternat Med"},{"key":"ref55","article-title":"CYP2J2 Targeting to Endothelial Cells Attenuates Adiposity and Vascular Dysfunction in Mice Fed a High-Fat Diet by Reprogramming Adipocyte Phenotype","author":"NG Abraham","year":"2014","journal-title":"Hypertension"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"980547","DOI":"10.1155\/2014\/980547","article-title":"HO-1 Upregulation Attenuates Adipocyte Dysfunction, Obesity, and Isoprostane Levels in Mice Fed High Fructose Diets","volume":"2014","author":"Z Khitan","year":"2014","journal-title":"J Nutr Metab"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/hum.2010.059","article-title":"Lentiviral-human heme oxygenase targeting endothelium improved vascular function in angiotensin II animal model of hypertension","volume":"22","author":"J Cao","year":"2011","journal-title":"Hum Gene Ther"},{"issue":"Suppl 1","key":"ref58","first-page":"S17","article-title":"Pathophysiology of nonalcoholic steatohepatitis","volume":"40","author":"AJ McCullough","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/hep.26491","article-title":"Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-alpha-converting enzyme activity in mice","volume":"58","author":"JX Jiang","year":"2013","journal-title":"Hepatology"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Vasko R, Xavier S, Chen J, Lin CH, Ratliff B, Rabadi M, et al. Endothelial Sirtuin 1 Deficiency Perpetrates Nephrosclerosis through Downregulation of Matrix Metalloproteinase-14: Relevance to Fibrosis of Vascular Senescence. J Am Soc Nephrol 2013.","DOI":"10.1681\/ASN.2013010069"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1464-5491.2007.02025.x","article-title":"Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens","volume":"24","author":"G Targher","year":"2007","journal-title":"Diabet Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2174\/138161208783497705","article-title":"Models for non-alcoholic fatty liver disease: a link with vascular risk","volume":"14","author":"E Xirouchakis","year":"2008","journal-title":"Curr Pharm Des"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1758-5996-3-37","article-title":"High fat diet enhances cardiac abnormalities in SHR rats: Protective role of heme oxygenase-adiponectin axis","volume":"3","author":"J Cao","year":"2011","journal-title":"Diabetol Metab Syndr"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1161\/CIRCULATIONAHA.108.778688","article-title":"Gene transfer of inducible nitric oxide synthase affords cardioprotection by upregulating heme oxygenase-1 via a nuclear factor-{kappa}B-dependent pathway","volume":"120","author":"Q Li","year":"2009","journal-title":"Circulation"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1194\/jlr.M800610-JLR200","article-title":"The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice","volume":"50","author":"SJ Peterson","year":"2009","journal-title":"J Lipid Res"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0259219","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000},"record-id":"33716"},{"DOI":"10.1371\/journal.pone.0259219","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T00:00:00Z","timestamp":1635984000000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0128648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T20:07:31Z","timestamp":1748462851000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0128648"}},"subtitle":[],"editor":[{"given":"Herv\u00e9","family":"Guillou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,22]]},"references-count":65,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0128648","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,22]]}}}